FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1814 May 1, 2003 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Zhang, L. PubMed Citation

To the Editor: Zhang et al. (Jan. 16 issue)¹ report that the presence of intratumoral T cells, detected by immunohistochemical analysis, correlates with an improved clinical outcome in patients with advanced ovarian carcinoma. However, it is not clear whether the count of the intratumoral T cells was performed on the primary ovarian tumor tissue or on the metastases and whether the primary and metastatic lesions were compared in terms of the presence of these cells.

Filippo Fraggetta, M.D.
Paolo Scollo, M.D.
Azienda Ospedaliera Cannizzaro
95126 Catania, Italy
filippofra@hotmail.com

Giuseppe Pelosi, M.D.
European Institute of Oncology
20141 Milan, Italy

1. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-213. [Free Full Text]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.